ASA. S. Shanoyan

A. S. Shanoyan

*This is an algorithmically generated author record based on publicly available information.

A. S. Shanoyan has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of circulating glutathione S-transferase Mu 3 with coronary and peripheral atherosclerosis and cardiovascular events: a 3-year follow-up study

    by M. A. Khadorich, N. G. Gumanova, A. S. Shanoyan, D. K. Vasiliev, N. L. Bogdanova, A. R. Kiselev, O. M. Drapkina, М. А. Хадорич, Н. Г. Гуманова, А. С. Шаноян, et al.

    Aim. To evaluate the association of circulating glutathione S-transferase Mu 3 (GSTM3) levels with atherosclerosis of various locations and cardiovascular events (CVEs) based on 3-year follow-up data. Material and methods . In a cohort of 216 patients who underwent coronary angiography, GSTM3 levels were measured in 173 randomly selected patients using enzyme-linked immunosorbent assay (ELISA). Patients were divided into two groups based on the median GSTM3 level (2,49 ng/ml): group 1 (< median) and group 2 (≥ median). The severity of coronary atherosclerosis was assessed using the Gensini score. The composite endpoint (revascularization, myocardial infarction, stroke) was recorded after 3 years via telephone survey. Results . The groups did not differ in sex, age, smoking status, or blood pressure levels. In group 2, the odds of severe coronary artery disease were 2,8 times higher (odds ratio (OR) =2,8; 95% confidence interval (CI): 1,38-5,85; p=0,004), and the odds of stenosis of any degree were 3,6 times higher (OR=3,6; 95% CI: 1,91-6,81; p=0,001). ROC analysis confirmed the association of GSTM3 levels with atherosclerotic lesions in coronary, extracranial, and femoral arteries (pConclusion. Elevated GSTM3 levels are associated with atherosclerosis and a higher risk of CVEs; however, this association with CVEs appears to be indirect.

  • The role of the metabotropic glutamate receptor 1 signaling pathway in the development of cardiovascular pathology

    by A. R. Levshina, N. G. Gumanova, L. V. Voskanian, A. S. Shanoyan, D. K. Vasiliev, O. M. Drapkina

    Metabotropic glutamate receptor 1 (mGluR1), traditionally studied in the context of neuronal signaling, has recently gained attention as a potential contributor to the pathogenesis of cardiovascular diseases. This review summarises current evidence on the role of mGluR1 in neurodegenerative, oncological, and — most importantly — cardiovascular diseases. We discuss the receptor structure, its classification as a GPCR family member, and the features of its intracellular signaling, including activation of the MAPK/ERK and PI3K/Akt pathways and regulation of transcription factors. It has been shown that, in addition to the central nervous system, mGluR1 is expressed in immune cells, the endothelium, vascular smooth muscle cells, and cardiomyocytes, suggesting its involvement in regulating inflammation, proliferation, and angiogenesis — key processes in atherogenesis. Special attention is given to data on glutamate accumulation in unstable atherosclerotic plaques and its association with local inflammation. We also note the lack of clinical studies evaluating mGluR1 concentrations in patients with coronary artery disease. Further investigation of mGluR1 as a potential biomarker and molecular target in cardiovascular pathology represents a promising direction.

  • Open Access

    Programmed cell death and its role in the atherosclerosis pathogenesis: the role of inhibitor of caspase-activated DNase in cardiovascular diseases and oncology

    by А. А. А. Мольс, N. G. Gumanova, L. V. Voskanyan, N. L. Bogdanova, A. S. Shanoyan, A. R. Kiselev

    Apoptosis is a programmed cell death, the final stage of which (deoxyribonucleic acid (DNA) fragmentation) is keyly catalyzed by the complex of caspase-activated DNase (CAD/DFF40) and its inhibitor (ICAD/DFF45). Normally, ICAD performs a dual function as follows: it facilitates the CAD enzyme folding and blocks its activity. When apoptosis is triggered, caspase-3 cleaves the ICAD/CAD complex, releasing activated CAD, which catalyzes DNA fragmentation. In atherosclerosis, due to impaired cell recycling, CAD activation transforms silent apoptosis into inflammatory necrosis, destabilizing the plaque. In oncology, by contrast, decreased CAD activity, for example, by strengtheв relationship with an ICAD inhibitor, can cause tumor resistance to chemotherapy and radiation therapy. Thus, the ICAD/CAD complex is an important molecular target. Its excessive activation is dangerous in atherosclerosis, and its insufficient activation is dangerous in cancer treatment.

  • Open Access

    Potential of carbon dioxide angiography in the treatment of critical renal artery lesions in a patient with chronic kidney disease: a case report

    by D. K. Vasiliev, Н. А. Араблинский, F. B. Shukurov, D. A. Feshchenko, M. T. Taliuridze, A. S. Shanoyan, N. P. Fedotova

    The combination of atherosclerotic coronary and renal system lesions is quite common in clinical practice, while the risk of cardiovascular complications in such patients is tens of times higher than in the general population, which is associated with a sharp acceleration of vascular damage. The use of minimally invasive surgery, in particular endovascular renal artery revascularization, can improve excretory renal function and delay the need for renal replacement therapy. However, the use of nephrotoxic contrast agents in the presence of chronic kidney disease in a patient can become a key limiting factor for the use of endovascular treatment methods. The way out of this situation is the use of non-contrast endovascular surgery under the carbon dioxide angiography and intravascular imaging guidance. The article presents a case of successful balloon angioplasty and stenting of critical stenosis of the right renal artery in a comorbid patient under the carbon dioxide angiography and intravascular ultrasound guidance.


  • Open Access

    First experience of implantation of a new-generation bioresorbable stent in a young patient with coronary artery disease: a case report

    by D. K. Vasiliev, Н. А. Араблинский, F. B. Shukurov, D. A. Feshchenko, M. T. Taliuridze, А. S. Shanoyan

    Implantation of a drug-eluting stent into the area of hemodynamically significant coronary artery lesion is a generally accepted and widespread method of coronary artery disease (CAD) treatment. However, rigid metallic frame in artery is associated with disrupted vascular biomechanics and neointimal proliferation in response to foreign material. These processes can lead to restenosis and/or late thrombosis of the implanted stent and, as a consequence, to the recurrence of CAD symptoms, as well as to adverse cardiovascular events. One of the options for solving the above problems is the implantation of bioresorbable stents. This technique already has an evidence base and is increasingly being introduced into routine clinical practice in certain groups of patients. The article presents a case of successful balloon angioplasty and stenting of the right coronary artery with a new-generation bioresorbable stent in a young patient with CAD.


  • Open Access

    Treatment of renal artery fibromuscular dysplasia with drug-eluting balloon angioplasty and intravascular imaging: a case report

    by F. B. Shukurov, M. T. Taliuridze, M. S. Kharlap, M. A. Kardashova, N. P. Fedotova, D. K. Vasiliev, D. A. Feshchenko, A. S. Shanoyan

    Fibromuscular dysplasia (FD) is a segmental, non-inflammatory and non-atherosclerotic disease of vascular smooth muscle of unknown etiology, which leads to stenosis of smalland medium-sized arteries. The choice of surgical treatment tactics for renal artery FD depends on the severity of clinical manifestations and the response to the conservative drug treatment used. Young age, female sex, high blood pressure with failure to achieve target values with therapy, as well as the absence of atherosclerotic involvement of other arterial systems gives reason to suspect renal artery FD. According to modern guidelines, the invasive treatment of hemodynamically significant renal artery stenoses includes transluminal drug-eluting balloon angioplasty. In this disease, renal artery stenting is not recommended. However, stent implantation is required if balloon angioplasty did not give the optimal result or in case of periprocedural complications, such as arterial dissection. Open reconstructive surgery is indicated for complex anatomy of the related artery, macroaneurysms in which stent grafts are ineffective, refractory intimal fibroplastic lesions, increased risk of endovascular treatment, or after unsuccessful endovascular intervention. The article presents a case of a young patient with renal artery FD, renovascular arterial hypertension, who successfully underwent renal artery transluminal drugeluting balloon angioplasty.


  • Open Access

    Clinical Case of IVUS-Guided Coronary Artery Stenting in a Patient with Chronic Renal Failure

    by D. K. Vasiliev, B. A. Rudenko, D. A. Feshchenko, F. B. Shukurov, A. S. Shanoyan

    Introduction. An expanding number of indications for PCI in patients with coronary heart disease and severe concomitant pathology are accompanied by a growing number of patients with chronic renal failure. Contrast-induced nephropathy (CIN) is recognized as a severe complication, aggravating the course of the underlying disease, and, moreover, reducing the life expectancy of the patients. Modern intravascular imaging technologies are widely implemented in real clinical practice of endovascular surgery. In the context of increasing number of PCI performed in patients with severe concomitant pathology, the IVUS-guidance will improve the quality of stenting, and, importantly, lessen the risks of CIN due to the reduction in contrast volume. Materials and methods. The paper presents a clinical case of IVUSguided stenting of the right coronary artery without contrast agent in a patient with chronic kidney disease and the following diagnosis: “Coronary heart disease. Effort angina, class III (dyspnea as anginal equivalent). Balloon angioplasty and stenting of circumflex artery and LAD. Hyperlipidemia 2a. Atherosclerosis of the aorta, brachiocephalic and coronary arteries. Stage 3 hypertension. Controlled Hypertension. Level IV CVD risk. Type 2 diabetes mellitus. Target glycated hemoglobin is less than 7.5%. Grade 2 obesity, exogenous-constitutional. Renal microlithiasis. CKD stage 4 (GFR 29 ml/min/1.73m2). Cerebrovascular disease. Chronic cerebral ischemia.” Results and discussion. In the described clinical case, a complete myocardial revascularization was achieved using IVUS-guidance and minimal amount of contrast agent in a patient with severe CKD. The advantage of minimally invasive endovascular interventions in a complex category of patients, demonstrated by the case, implies expanded possibilities for providing high-tech care to patients with significant limitations in the use of contrast agents due to severe CKD with a high risk of CIN. Conclusion. Today, an increasing number of X-ray operating rooms in Russia are equipped with intravascular technologies, ensuring their wider use. The skills and knowledge in using IVUS imply rare application of contrast agents, thereby lessening the risk of CKD and, as a consequence, improving the prognosis of patients with reduced renal function and high risk of CKD.


  • Open Access

    "Trust the eye, but verify". Case report

    by M. T. Taliuridze, F. B. Shukurov, A. S. Shanoyan

    Coronary angiography is today a routine method for assessing the coronary arteries. However, in practice, invasive cardiologists daily face difficulties in assessing the coronary system. The publication considers the management of an elderly patient with class III angina and a dubious exercise test.

  • Open Access

    Endovascular Treatment of a Patient with Multivessel Deсease Combined with Chronic Occlusion of the Right Coronary Artery

    by D. K. Vasiliev, B. A. Rudenko, D. A. Feshchenko, F. B. Shukurov, A. S. Shanoyan

    Introduction. Coronary hagiography revealed 70%-prevalence of multivessel coronary lesions. Chronic coronary occlusion (CCO) occurs in approximately 20 % of patients with coronary heart disease. Endovascular recanalization of CCO is associated with technical difficulties and the risk of complications. In this regard, patients with CCO rarely undergo revascularization, which leads to incomplete myocardial revascularization.Materials and methods. Patient M., male, 64, was hospitalized at the National Medical Research Center for Therapy and Preventive Medicine in February 2020 with a diagnosis of CHD. Stable angina, FC III, multivessel coronary lesions. The recanalization of chronic occlusion of the right coronary artery was performed at the first stage. During the next stage of revascularization of the left main coronary artery, an acute occlusion of the circumflex artery occurred. Despite the acute occlusion, no ischemic dynamics wasm reported on the electrocardiogram, there were no complaints, hemodynamics was stable. Ischemic events did not occur due to the formed network of collaterals out of the system of the right coronary artery. This allowed the complication to be corrected without consequences for the patient. Results and discussion. Thanks to the accumulated experience and advanced technologies, the success rate of recanalization has reached 90–95 %, and complications are not more common than in cases of stenting of non-occlusive lesions. The conducted studies have proved that successful recanalization of CCO improves the patient’s clinical and functional status, intracardiac hemodynamics and quality of life.Conclusion. The clinical case given above clearly demonstrates the need for endovascular revascularization of CCO. The formed collateral network ensured blood flow in the area of acute occlusion and prevented the development of ischemia and myocardial infarction.


  • Open Access

    Effectiveness of radiofrequency renal denervation in diseases with increased sympathetic nervous system activity

    by B. A. Rudenko, D. A. Feshchenko, D. K. Vasiliev, F. B. Shukurov, A. S. Shanoyan, M. N. Mamedov, O. M. Drapkina

    The article discusses the role of sympathetic nervous system hyperactivity in the pathogenesis of various pathologies (hypertension, heart failure, atrial fibrillation, metabolic syndrome, diabetes and systemic inflammatory response syndrome). On the example of large randomized clinical trials using catheter-based radiofrequency ablation, the antihypertensive effect in patients with uncontrolled hypertension has been proven. The first experimental and clinical studies on the effectiveness of renal denervation in reducing the activity of inflammatory markers, the incidence of atrial fibrillation and ventricular arrhythmia episodes, and improving the left ventricular contractility. The first clinical results of the favorable effect of renal denervation on carbohydrate metabolism (insulin resistance and glycemic level) in patients with metabolic syndrome and diabetes have been studied in detail.